Efficacy and Safety of a 3‐Weekly TS‐1 Adjuvant Regimen in Advanced Gastric Cancer: A Pilot Study
ABSTRACT Background TS‐1 at 80 mg/m2/day for 4 weeks followed by a 2‐week rest is standard adjuvant therapy for stage II/III Advanced Gastric Cancer (AGC). TS‐1 for 1 year (8 courses) is highly recommended. We investigated the efficacy and safety of an adjuvant 3‐weekly TS‐1 regimen for AGC. Methods...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.71079 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|